case_id,slide_id,submitter_id,tumor_type,project_id,site_of_resection_or_biopsy,sex,OncotreeCode,cancer_type_detailed,tissue_source_site,is_code_valid,mpp,op,level0_mag,OncoTreeSiteCode,disc_label,age_at_initial_pathologic_diagnosis,race,ajcc_pathologic_tumor_stage,clinical_stage,histological_type,histological_grade,initial_pathologic_dx_year,menopause_status,birth_days_to,vital_status,tumor_status,last_contact_days_to,death_days_to,cause_of_death,new_tumor_event_type,new_tumor_event_site,new_tumor_event_site_other,new_tumor_event_dx_days_to,treatment_outcome_first_course,margin_status,residual_tumor,os_censorship,os_survival_days,dss_censorship,dss_survival_days,dfi_censorship,dfi_survival_days,pfi_censorship,pfi_survival_days,redaction,pfi_v1_censorship,pfi_v1_survival_days,pfi_v2_censorship,pfi_v2_survival_days,pfs_censorship,pfs_survival_days,dss_cr_censorship,dss_cr_survival_days,dfi_cr_censorship,dfi_cr_survival_days,pfi_cr_censorship,pfi_cr_survival_days,pfi_v1_cr_censorship,pfi_v1_cr_survival_days,pfi_v2_cr_censorship,pfi_v2_cr_survival_days
TCGA-5B-A90C,TCGA-5B-A90C-01Z-00-DX1.3F24BFBE-425C-456A-AFFF-55CB7B43FC3E,TCGA-5B-A90C,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,5B,True,0.2525,40,40.0,UTERUS,6.0,69.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25518.0,Alive,TUMOR FREE,1202.0,,[Not Available],Locoregional Recurrence,"Other, specify",right pelvic mass,517.0,[Not Available],,,1.0,1202.0,1.0,1202.0,,,0.0,517.0,,0.0,517.0,0.0,517.0,0.0,517.0,1.0,1202.0,,,0.0,517.0,0.0,517.0,0.0,517.0
TCGA-AW-A1PO,TCGA-AW-A1PO-01Z-00-DX1.43719BD6-1D42-40F7-A129-F245B1692E2E,TCGA-AW-A1PO,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,AW,True,0.2525,40,40.0,UTERUS,0.0,66.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24225.0,Alive,TUMOR FREE,17.0,,[Not Available],,,,,[Not Available],,,1.0,17.0,1.0,17.0,,,1.0,17.0,,1.0,17.0,1.0,17.0,1.0,17.0,1.0,17.0,,,1.0,17.0,1.0,17.0,1.0,17.0
TCGA-B5-A0JN,TCGA-B5-A0JN-01Z-00-DX1.8B663EC1-0F34-4699-A554-4D8FE02E287D,TCGA-B5-A0JN,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,84.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30933.0,Alive,TUMOR FREE,2445.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2445.0,1.0,2445.0,,,1.0,2445.0,,1.0,2445.0,1.0,2445.0,1.0,2445.0,1.0,2445.0,,,1.0,2445.0,1.0,2445.0,1.0,2445.0
TCGA-B5-A0JR,TCGA-B5-A0JR-01Z-00-DX1.997DA62A-D4E3-46FD-8948-4DBE23C0E8E9,TCGA-B5-A0JR,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,73.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26814.0,Alive,TUMOR FREE,1731.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0,,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0,1.0,1731.0
TCGA-B5-A0JS,TCGA-B5-A0JS-01Z-00-DX1.076A07A7-86BF-419A-9E32-F2EBD4CD3FCB,TCGA-B5-A0JS,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,54.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19995.0,Alive,TUMOR FREE,2627.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0,,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0,1.0,2627.0
TCGA-B5-A0JT,TCGA-B5-A0JT-01Z-00-DX1.98C557F8-8657-4741-BF55-8D053C449110,TCGA-B5-A0JT,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,63.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23041.0,Alive,TUMOR FREE,1682.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0,,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0,1.0,1682.0
TCGA-B5-A0JU,TCGA-B5-A0JU-01Z-00-DX1.C07DE627-DE9C-454D-82FF-8B5444D58585,TCGA-B5-A0JU,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,57.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21159.0,Alive,TUMOR FREE,1802.0,,[Not Available],,,,,[Not Available],,,1.0,1802.0,1.0,1802.0,,,1.0,1802.0,,1.0,1802.0,1.0,1802.0,1.0,1802.0,1.0,1802.0,,,1.0,1802.0,1.0,1802.0,1.0,1802.0
TCGA-B5-A0JV,TCGA-B5-A0JV-01Z-00-DX1.820AB1F8-A37E-4882-A895-0C84E423A627,TCGA-B5-A0JV,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,63.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23295.0,Alive,TUMOR FREE,2616.0,,[Not Available],Locoregional Disease,"Other, specify",vaginal wall,698.0,Complete Remission/Response,,,1.0,2616.0,1.0,2616.0,0.0,698.0,0.0,698.0,,0.0,698.0,0.0,698.0,0.0,698.0,1.0,2616.0,0.0,698.0,0.0,698.0,0.0,698.0,0.0,698.0
TCGA-B5-A0JX,TCGA-B5-A0JX-01Z-00-DX1.D12E7005-E87A-4D42-B042-6280EA7F0D47,TCGA-B5-A0JX,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,62.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22834.0,Alive,TUMOR FREE,1787.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0,,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0,1.0,1787.0
TCGA-B5-A0JY,TCGA-B5-A0JY-01Z-00-DX1.BECF9195-2DAF-4646-844F-6DC9A794C515,TCGA-B5-A0JY,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,50.0,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18475.0,Alive,TUMOR FREE,2107.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0,,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0,1.0,2107.0
TCGA-B5-A0JZ,TCGA-B5-A0JZ-01Z-00-DX1.D31EED39-7498-4D66-BE6A-7D075F5DA4D5,TCGA-B5-A0JZ,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,60.0,WHITE,[Not Applicable],Stage IIIC1,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22106.0,Alive,TUMOR FREE,2173.0,,[Not Available],Metastatic,"Other, specify",inguinal lymph node,356.0,Progressive Disease,,,1.0,2173.0,1.0,2173.0,,,0.0,356.0,,0.0,356.0,0.0,356.0,0.0,356.0,1.0,2173.0,,,0.0,356.0,0.0,356.0,0.0,356.0
TCGA-B5-A0K0,TCGA-B5-A0K0-01Z-00-DX1.A407CC6A-C63B-41D3-86AA-F2E30DF57CF2,TCGA-B5-A0K0,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,6.0,48.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Indeterminate (neither Pre or Postmenopausal),-17810.0,Alive,TUMOR FREE,1478.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0,,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0,1.0,1478.0
TCGA-B5-A0K1,TCGA-B5-A0K1-01Z-00-DX1.943364EC-5CA3-4969-BEB1-435F672B5137,TCGA-B5-A0K1,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,6.0,69.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25291.0,Alive,TUMOR FREE,1110.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0,,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0,1.0,1110.0
TCGA-B5-A0K2,TCGA-B5-A0K2-01Z-00-DX1.7856E75D-42C0-4A7A-BA5A-2B9092B7754E,TCGA-B5-A0K2,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,54.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Indeterminate (neither Pre or Postmenopausal),-20080.0,Alive,TUMOR FREE,2209.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0,,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0,1.0,2209.0
TCGA-B5-A0K3,TCGA-B5-A0K3-01Z-00-DX1.ACC15A3D-67F0-49C8-9B41-18A2D4EBF5C8,TCGA-B5-A0K3,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,4.0,62.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22664.0,Dead,WITH TUMOR,,830.0,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,256.0,[Not Available],,,0.0,830.0,0.0,830.0,,,0.0,256.0,,0.0,256.0,0.0,256.0,0.0,256.0,0.0,830.0,,,0.0,256.0,0.0,256.0,0.0,256.0
TCGA-B5-A0K4,TCGA-B5-A0K4-01Z-00-DX1.4D162F7D-FCD9-441B-9A64-EEAFC551FF4C,TCGA-B5-A0K4,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,51.0,[Not Available],[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18631.0,Alive,TUMOR FREE,1757.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0,,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0,1.0,1757.0
TCGA-B5-A0K6,TCGA-B5-A0K6-01Z-00-DX1.6034D569-E7E4-432A-A5B0-AD365EFB7F29,TCGA-B5-A0K6,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,58.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21515.0,Alive,TUMOR FREE,1953.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0,,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0,1.0,1953.0
TCGA-B5-A0K7,TCGA-B5-A0K7-01Z-00-DX1.51DB82B5-21F6-4CB0-94CE-8248F489AC0C,TCGA-B5-A0K7,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,64.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23429.0,Alive,TUMOR FREE,1933.0,,[Not Available],Metastatic,"Other, specify",vagina,322.0,Complete Remission/Response,,,1.0,1933.0,1.0,1933.0,0.0,322.0,0.0,322.0,,0.0,322.0,0.0,322.0,0.0,322.0,1.0,1933.0,0.0,322.0,0.0,322.0,0.0,322.0,0.0,322.0
TCGA-B5-A0K8,TCGA-B5-A0K8-01Z-00-DX1.45F0FC3C-B5F8-453A-8822-BB06E18E63B1,TCGA-B5-A0K8,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,4.0,71.0,WHITE,[Not Applicable],Stage IB,Serous endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25992.0,Alive,TUMOR FREE,847.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0,,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0,1.0,847.0
TCGA-B5-A0K9,TCGA-B5-A0K9-01Z-00-DX1.D4D4BB47-9CE6-48E6-AD17-8515E03393D4,TCGA-B5-A0K9,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,2.0,88.0,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32289.0,Dead,TUMOR FREE,,409.0,[Not Available],,,,,Complete Remission/Response,,,0.0,409.0,1.0,409.0,1.0,409.0,1.0,409.0,,1.0,409.0,1.0,409.0,0.0,409.0,-1.0,409.0,-1.0,409.0,-1.0,409.0,-1.0,409.0,-1.0,409.0
TCGA-B5-A0KB,TCGA-B5-A0KB-01Z-00-DX1.230C49BF-BF64-4AF1-95EE-5B6040EB5EE4,TCGA-B5-A0KB,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,4.0,62.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22669.0,Alive,WITH TUMOR,824.0,,[Not Available],Locoregional Disease,"Other, specify",cul de sac mass,689.0,Complete Remission/Response,,,1.0,824.0,1.0,824.0,0.0,689.0,0.0,689.0,,0.0,689.0,0.0,689.0,0.0,689.0,1.0,824.0,0.0,689.0,0.0,689.0,0.0,689.0,0.0,689.0
TCGA-B5-A11E,TCGA-B5-A11E-01Z-00-DX1.5B371781-5370-4411-9C8B-178BF6691D8A,TCGA-B5-A11E,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,53.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Peri (6-12 months since last menstrual period),-19458.0,Alive,TUMOR FREE,1820.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0,,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0,1.0,1820.0
TCGA-B5-A11F,TCGA-B5-A11F-01Z-00-DX1.3F1C053D-E81E-4C8D-965D-6F3DE29D9511,TCGA-B5-A11F,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,55.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20171.0,Alive,TUMOR FREE,5651.0,,[Not Available],Metastatic,Bone,,1610.0,Complete Remission/Response,,,1.0,5651.0,1.0,5651.0,0.0,1610.0,0.0,1610.0,,0.0,1610.0,0.0,1610.0,0.0,1610.0,1.0,5651.0,0.0,1610.0,0.0,1610.0,0.0,1610.0,0.0,1610.0
TCGA-B5-A11G,TCGA-B5-A11G-01Z-00-DX1.A301CAD6-1059-4AE5-B504-D0BE220D745A,TCGA-B5-A11G,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,71.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2001.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25995.0,Alive,TUMOR FREE,3448.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0,,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0,1.0,3448.0
TCGA-B5-A11H,TCGA-B5-A11H-01Z-00-DX1.69DD8C58-E038-4342-BC94-6D1BA4BCAFF6,TCGA-B5-A11H,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,67.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G2,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24556.0,Alive,TUMOR FREE,2687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0,,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0,1.0,2687.0
TCGA-B5-A11I,TCGA-B5-A11I-01Z-00-DX1.7E8DD2BF-756B-4E51-AA97-32A3FE267825,TCGA-B5-A11I,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,65.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2005.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23857.0,Alive,TUMOR FREE,2303.0,,[Not Available],Metastatic,Lung,,705.0,Complete Remission/Response,,,1.0,2303.0,1.0,2303.0,,,0.0,705.0,,0.0,705.0,0.0,705.0,0.0,705.0,1.0,2303.0,,,0.0,705.0,0.0,705.0,0.0,705.0
TCGA-B5-A11J,TCGA-B5-A11J-01Z-00-DX1.8BD1392A-B5C1-4BE8-A04F-593417AF7B70,TCGA-B5-A11J,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,64.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23485.0,Alive,TUMOR FREE,1656.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0,,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0,1.0,1656.0
TCGA-B5-A11L,TCGA-B5-A11L-01Z-00-DX1.AC8D3A32-90B3-4629-AD83-DEC67DAF7D1B,TCGA-B5-A11L,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,71.0,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G2,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26120.0,Dead,TUMOR FREE,,2240.0,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal Apex,131.0,Complete Remission/Response,,,0.0,2240.0,1.0,2240.0,0.0,131.0,0.0,131.0,,0.0,131.0,0.0,131.0,0.0,131.0,-1.0,2240.0,0.0,131.0,0.0,131.0,0.0,131.0,0.0,131.0
TCGA-B5-A11M,TCGA-B5-A11M-01Z-00-DX1.DAC70FB9-527B-44C9-B173-124464719B51,TCGA-B5-A11M,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,6.0,43.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-16063.0,Alive,TUMOR FREE,1362.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0,,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0,1.0,1362.0
TCGA-B5-A11N,TCGA-B5-A11N-01Z-00-DX1.871B0105-6653-4ED4-80D4-473BE082B658,TCGA-B5-A11N,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,69.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2007.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25442.0,Alive,TUMOR FREE,1876.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0,,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0,1.0,1876.0
TCGA-B5-A11O,TCGA-B5-A11O-01Z-00-DX1.3423C2D8-4063-4430-BB3A-08B3B8799C7B,TCGA-B5-A11O,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,62.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22720.0,Alive,TUMOR FREE,2609.0,,[Not Available],New Primary Tumor,"Other, specify",Right Breast,1924.0,Complete Remission/Response,,,1.0,2609.0,1.0,2609.0,1.0,2609.0,0.0,1924.0,,1.0,2609.0,1.0,2609.0,0.0,1924.0,1.0,2609.0,1.0,2609.0,0.0,1924.0,1.0,2609.0,1.0,2609.0
TCGA-B5-A11P,TCGA-B5-A11P-01Z-00-DX1.63BC1838-D41F-4C93-B61C-3F49A5ED4680,TCGA-B5-A11P,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,87.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-32047.0,Alive,TUMOR FREE,1583.0,,[Not Available],,,,,[Not Available],,,1.0,1583.0,1.0,1583.0,,,1.0,1583.0,,1.0,1583.0,1.0,1583.0,1.0,1583.0,1.0,1583.0,,,1.0,1583.0,1.0,1583.0,1.0,1583.0
TCGA-B5-A11Q,TCGA-B5-A11Q-01Z-00-DX1.F6301E11-F37B-4FE0-9D17-CC8AED593509,TCGA-B5-A11Q,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,5.0,64.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23538.0,Alive,TUMOR FREE,976.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0,,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0,1.0,976.0
TCGA-B5-A11R,TCGA-B5-A11R-01Z-00-DX1.E8573F3E-1500-4BDF-8930-A853E62A984F,TCGA-B5-A11R,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2485,40,40.0,UTERUS,7.0,51.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2008.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-18878.0,Alive,TUMOR FREE,2349.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0,,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0,1.0,2349.0
TCGA-B5-A11S,TCGA-B5-A11S-01Z-00-DX1.2A76EB22-572C-43C3-9104-D108AA93AE4D,TCGA-B5-A11S,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,7.0,63.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23085.0,Alive,TUMOR FREE,2229.0,,[Not Available],New Primary Tumor,"Other, specify",Breast,41.0,Complete Remission/Response,,,1.0,2229.0,1.0,2229.0,1.0,2229.0,0.0,41.0,,1.0,2229.0,1.0,2229.0,0.0,41.0,1.0,2229.0,1.0,2229.0,0.0,41.0,1.0,2229.0,1.0,2229.0
TCGA-B5-A11U,TCGA-B5-A11U-01Z-00-DX1.E017CB6D-71F3-4A99-B6BC-184C36D0B955,TCGA-B5-A11U,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,2.0,74.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IVB,Endometrioid endometrial adenocarcinoma,G3,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27160.0,Alive,TUMOR FREE,509.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,509.0,1.0,509.0,,,1.0,509.0,,1.0,509.0,1.0,509.0,1.0,509.0,1.0,509.0,,,1.0,509.0,1.0,509.0,1.0,509.0
TCGA-B5-A11V,TCGA-B5-A11V-01Z-00-DX1.A4D88075-88AA-45D2-B6BB-E214004D4EB8,TCGA-B5-A11V,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,3.0,64.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23630.0,Alive,TUMOR FREE,595.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0,,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0,1.0,595.0
TCGA-B5-A11W,TCGA-B5-A11W-01Z-00-DX1.C5466A91-D7A6-4797-B6D1-C4FD8FABDCA6,TCGA-B5-A11W,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,3.0,61.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22365.0,Alive,TUMOR FREE,593.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0,,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0,1.0,593.0
TCGA-B5-A11X,TCGA-B5-A11X-01Z-00-DX1.882E081F-49E3-4533-B0C3-BA0CCF83E9CB,TCGA-B5-A11X,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,3.0,66.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24217.0,Alive,TUMOR FREE,596.0,,[Not Available],Metastatic,"Other, specify",lymph nodes,397.0,[Not Available],,,1.0,596.0,1.0,596.0,,,0.0,397.0,,0.0,397.0,0.0,397.0,0.0,397.0,1.0,596.0,,,0.0,397.0,0.0,397.0,0.0,397.0
TCGA-B5-A11Y,TCGA-B5-A11Y-01Z-00-DX1.CA396120-026C-4369-A0D8-189D19E85181,TCGA-B5-A11Y,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,3.0,59.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21860.0,Alive,TUMOR FREE,560.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0,,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0,1.0,560.0
TCGA-B5-A11Z,TCGA-B5-A11Z-01Z-00-DX1.5F0550FA-7B97-4A77-A3AA-4686C75A96B8,TCGA-B5-A11Z,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,3.0,61.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22505.0,Alive,TUMOR FREE,528.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0,,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0,1.0,528.0
TCGA-B5-A121,TCGA-B5-A121-01Z-00-DX1.EA4B5585-0DD5-4F4A-876E-67031376C9FC,TCGA-B5-A121,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.248,40,40.0,UTERUS,2.0,57.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21018.0,Alive,TUMOR FREE,504.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0,,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0,1.0,504.0
TCGA-B5-A1MR,TCGA-B5-A1MR-01Z-00-DX1.A6906654-011F-4BD3-9A6C-365B3F0706BB,TCGA-B5-A1MR,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,65.0,WHITE,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G3,1995.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24017.0,Alive,TUMOR FREE,6859.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0,,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0,1.0,6859.0
TCGA-B5-A1MS,TCGA-B5-A1MS-01Z-00-DX1.CB41B567-F820-45FA-8808-21BC87BAE519,TCGA-B5-A1MS,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,60.0,WHITE,[Not Applicable],Stage IC,Serous endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22068.0,Dead,WITH TUMOR,,3112.0,[Not Available],Locoregional Recurrence,"Other, specify",Supraclavicular Fossa,2706.0,Partial Remission/Response,,,0.0,3112.0,0.0,3112.0,,,0.0,2706.0,,0.0,2706.0,0.0,2706.0,0.0,2706.0,0.0,3112.0,,,0.0,2706.0,0.0,2706.0,0.0,2706.0
TCGA-B5-A1MU,TCGA-B5-A1MU-01Z-00-DX1.BBA9A482-E971-4A4A-A852-15D3DDBF8A7F,TCGA-B5-A1MU,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,79.0,WHITE,[Not Applicable],Stage IVB,Serous endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-29027.0,Dead,WITH TUMOR,,1548.0,[Not Available],New Primary Tumor,"Other, specify",Breast,1365.0,Complete Remission/Response,,,0.0,1548.0,0.0,1548.0,,,0.0,1365.0,,1.0,1548.0,1.0,1548.0,0.0,1365.0,0.0,1548.0,,,0.0,1365.0,-1.0,1548.0,-1.0,1548.0
TCGA-B5-A1MV,TCGA-B5-A1MV-01Z-00-DX1.5E65B748-D490-4A38-A45C-14F27C31D243,TCGA-B5-A1MV,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,84.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-30926.0,Alive,TUMOR FREE,1565.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0,,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0,1.0,1565.0
TCGA-B5-A1MW,TCGA-B5-A1MW-01Z-00-DX1.b25dd862-1a98-472e-a4d6-53c622e8b5fb,TCGA-B5-A1MW,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2511,40,40.0,UTERUS,2.0,55.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20183.0,Alive,TUMOR FREE,447.0,,[Not Available],Locoregional Disease,"Other, specify",vaginal cuff,311.0,Complete Remission/Response,,,1.0,447.0,1.0,447.0,0.0,311.0,0.0,311.0,,0.0,311.0,0.0,311.0,0.0,311.0,1.0,447.0,0.0,311.0,0.0,311.0,0.0,311.0,0.0,311.0
TCGA-B5-A1MX,TCGA-B5-A1MX-01Z-00-DX1.FAC60C1A-5927-403E-BCC2-E92F2F08ADC4,TCGA-B5-A1MX,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,6.0,47.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-17320.0,Alive,TUMOR FREE,1473.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0,,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0,1.0,1473.0
TCGA-B5-A1MY,TCGA-B5-A1MY-01Z-00-DX1.DA3AB92F-1B5A-4ACF-A144-67F7DC46CCE6,TCGA-B5-A1MY,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,1.0,62.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22805.0,Dead,WITH TUMOR,,361.0,[Not Available],Locoregional Disease,"Other, specify",peritoneum,333.0,[Not Available],,,0.0,361.0,0.0,361.0,,,0.0,333.0,,0.0,333.0,0.0,333.0,0.0,333.0,0.0,361.0,,,0.0,333.0,0.0,333.0,0.0,333.0
TCGA-B5-A1MZ,TCGA-B5-A1MZ-01Z-00-DX1.E652BC81-D2D3-4FFB-A1BD-74829382339A,TCGA-B5-A1MZ,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,54.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G1,2010.0,Indeterminate (neither Pre or Postmenopausal),-19955.0,Alive,TUMOR FREE,1598.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vagina,613.0,Complete Remission/Response,,,1.0,1598.0,1.0,1598.0,0.0,613.0,0.0,613.0,,0.0,613.0,0.0,613.0,0.0,613.0,1.0,1598.0,0.0,613.0,0.0,613.0,0.0,613.0,0.0,613.0
TCGA-B5-A1N2,TCGA-B5-A1N2-01Z-00-DX1.B830D815-BD34-4939-BAE9-B75F0660A68F,TCGA-B5-A1N2,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,5.0,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25612.0,Dead,WITH TUMOR,,954.0,[Not Available],Distant Metastasis,Brain,,804.0,Complete Remission/Response,,,0.0,954.0,0.0,954.0,0.0,804.0,0.0,804.0,,0.0,804.0,0.0,804.0,0.0,804.0,0.0,954.0,0.0,804.0,0.0,804.0,0.0,804.0,0.0,804.0
TCGA-B5-A3F9,TCGA-B5-A3F9-01Z-00-DX1.1A9F6606-71D0-45C4-84BF-D3F8F07E0732,TCGA-B5-A3F9,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,56.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2003.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20523.0,Alive,TUMOR FREE,4155.0,,[Not Available],,,,,[Not Available],,,1.0,4155.0,1.0,4155.0,,,1.0,4155.0,,1.0,4155.0,1.0,4155.0,1.0,4155.0,1.0,4155.0,,,1.0,4155.0,1.0,4155.0,1.0,4155.0
TCGA-B5-A3FA,TCGA-B5-A3FA-01Z-00-DX1.AD6F12EA-9E77-454A-96A9-C087778BC34D,TCGA-B5-A3FA,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,73.0,WHITE,[Not Applicable],Stage IC,Endometrioid endometrial adenocarcinoma,G3,2004.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26850.0,Alive,TUMOR FREE,2929.0,,[Not Available],,,,,[Not Available],,,1.0,2929.0,1.0,2929.0,,,1.0,2929.0,,1.0,2929.0,1.0,2929.0,1.0,2929.0,1.0,2929.0,,,1.0,2929.0,1.0,2929.0,1.0,2929.0
TCGA-B5-A3FB,TCGA-B5-A3FB-01Z-00-DX1.A48E8A92-79A6-4D7E-940B-25B54B35619E,TCGA-B5-A3FB,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26779.0,Alive,TUMOR FREE,2844.0,,[Not Available],,,,,[Not Available],,,1.0,2844.0,1.0,2844.0,,,1.0,2844.0,,1.0,2844.0,1.0,2844.0,1.0,2844.0,1.0,2844.0,,,1.0,2844.0,1.0,2844.0,1.0,2844.0
TCGA-B5-A3FC,TCGA-B5-A3FC-01Z-00-DX1.156D066B-6242-40A2-B7AF-9BC02A8EA053,TCGA-B5-A3FC,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,7.0,53.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2006.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-19422.0,Alive,TUMOR FREE,2185.0,,[Not Available],,,,,[Not Available],,,1.0,2185.0,1.0,2185.0,,,1.0,2185.0,,1.0,2185.0,1.0,2185.0,1.0,2185.0,1.0,2185.0,,,1.0,2185.0,1.0,2185.0,1.0,2185.0
TCGA-B5-A3FD,TCGA-B5-A3FD-01Z-00-DX1.2DD780C5-E07F-4F84-968B-3B1800BB7D7D,TCGA-B5-A3FD,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,6.0,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2009.0,Indeterminate (neither Pre or Postmenopausal),-25813.0,Dead,TUMOR FREE,,1197.0,[Not Available],Locoregional Recurrence,"Other, specify",endometrium,562.0,[Not Available],,,0.0,1197.0,1.0,1197.0,,,0.0,562.0,,0.0,562.0,0.0,562.0,0.0,562.0,-1.0,1197.0,,,0.0,562.0,0.0,562.0,0.0,562.0
TCGA-B5-A3FH,TCGA-B5-A3FH-01Z-00-DX1.6AFA4BA5-93E2-4E5A-9DB5-0441F070DA74,TCGA-B5-A3FH,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2456,40,40.0,UTERUS,4.0,74.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27221.0,Alive,TUMOR FREE,841.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0,,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0,1.0,841.0
TCGA-B5-A3S1,TCGA-B5-A3S1-01Z-00-DX1.C730ECCC-33CC-48EB-B25B-53E6926217E9,TCGA-B5-A3S1,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2456,40,40.0,UTERUS,5.0,71.0,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26031.0,Alive,WITH TUMOR,902.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0,,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0,1.0,902.0
TCGA-B5-A5OC,TCGA-B5-A5OC-01Z-00-DX1.ACC32938-6C55-4A0C-AA70-FD947D31698D,TCGA-B5-A5OC,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,B5,True,0.2525,40,40.0,UTERUS,6.0,71.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G3,2011.0,[Not Available],-26109.0,Alive,TUMOR FREE,1249.0,,[Not Available],,,,,[Not Available],,,1.0,1249.0,1.0,1249.0,,,1.0,1249.0,,1.0,1249.0,1.0,1249.0,1.0,1249.0,1.0,1249.0,,,1.0,1249.0,1.0,1249.0,1.0,1249.0
TCGA-B5-A5OD,TCGA-B5-A5OD-01Z-00-DX1.CC68EF1E-F8FE-4482-964C-9D57E8C38995,TCGA-B5-A5OD,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2525,40,40.0,UTERUS,6.0,67.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2011.0,[Not Available],-24775.0,Alive,TUMOR FREE,1038.0,,[Not Available],,,,,[Not Available],,,1.0,1038.0,1.0,1038.0,,,1.0,1038.0,,1.0,1038.0,1.0,1038.0,1.0,1038.0,1.0,1038.0,,,1.0,1038.0,1.0,1038.0,1.0,1038.0
TCGA-B5-A5OE,TCGA-B5-A5OE-01Z-00-DX1.73EAD167-3041-4498-8A5A-E30CABE85761,TCGA-B5-A5OE,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,B5,True,0.2525,40,40.0,UTERUS,6.0,68.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC2,Serous endometrial adenocarcinoma,G3,2011.0,[Not Available],-24905.0,Alive,TUMOR FREE,1063.0,,[Not Available],,,,,[Not Available],,,1.0,1063.0,1.0,1063.0,,,1.0,1063.0,,1.0,1063.0,1.0,1063.0,1.0,1063.0,1.0,1063.0,,,1.0,1063.0,1.0,1063.0,1.0,1063.0
TCGA-BK-A0C9,TCGA-BK-A0C9-01Z-00-DX2.0A8A34AC-E54C-44B6-8CF2-4FCC9C907A37,TCGA-BK-A0C9,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,6.0,57.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20876.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0
TCGA-BK-A0C9,TCGA-BK-A0C9-01Z-00-DX1.4838B17E-8151-4AE0-9A58-2CBA761D9A17,TCGA-BK-A0C9,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,,57.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2009.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20876.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0
TCGA-BK-A0CA,TCGA-BK-A0CA-01Z-00-DX1.1A831454-1A9A-4E7B-BF04-28638F715727,TCGA-BK-A0CA,Primary,TCGA-UCEC,Endometrium,F,UCEC,Endometrial Carcinoma,BK,True,0.2465,40,40.0,UTERUS,6.0,61.0,WHITE,[Not Applicable],Stage IIIC,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378.0,Alive,TUMOR FREE,1064.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0
TCGA-BK-A0CA,TCGA-BK-A0CA-01Z-00-DX2.ABEC0908-BE96-4C16-9F34-04ADA70852AD,TCGA-BK-A0CA,Primary,TCGA-UCEC,Endometrium,F,UCEC,Endometrial Carcinoma,BK,True,0.2465,40,40.0,UTERUS,,61.0,WHITE,[Not Applicable],Stage IIIC,Mixed serous and endometrioid,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22378.0,Alive,TUMOR FREE,1064.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0,1.0,1064.0
TCGA-BK-A0CB,TCGA-BK-A0CB-01Z-00-DX2.FF5ACD4B-276F-4530-AC93-490CE8C1C394,TCGA-BK-A0CB,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,6.0,60.0,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0
TCGA-BK-A0CB,TCGA-BK-A0CB-01Z-00-DX1.C53BB624-6204-4977-95C9-E54B500E41A5,TCGA-BK-A0CB,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,,60.0,WHITE,[Not Applicable],Stage IIIC,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21930.0,Alive,TUMOR FREE,1092.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0,1.0,1092.0
TCGA-BK-A0CC,TCGA-BK-A0CC-01Z-00-DX1.45981EB5-9C09-4AF4-8C8B-DA514858448A,TCGA-BK-A0CC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,BK,True,0.2465,40,40.0,UTERUS,6.0,69.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25479.0,Alive,WITH TUMOR,1067.0,,[Not Available],Locoregional Recurrence,"Other, specify",Right Pelvic Mass,1010.0,Complete Remission/Response,,,1.0,1067.0,1.0,1067.0,0.0,1010.0,0.0,1010.0,,0.0,1010.0,0.0,1010.0,0.0,1010.0,1.0,1067.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0
TCGA-BK-A0CC,TCGA-BK-A0CC-01Z-00-DX2.67D09615-834B-4520-9AE0-D88DB23508B5,TCGA-BK-A0CC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,BK,True,0.2465,40,40.0,UTERUS,,69.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25479.0,Alive,WITH TUMOR,1067.0,,[Not Available],Locoregional Recurrence,"Other, specify",Right Pelvic Mass,1010.0,Complete Remission/Response,,,1.0,1067.0,1.0,1067.0,0.0,1010.0,0.0,1010.0,,0.0,1010.0,0.0,1010.0,0.0,1010.0,1.0,1067.0,0.0,1010.0,0.0,1010.0,0.0,1010.0,0.0,1010.0
TCGA-BK-A139,TCGA-BK-A139-01Z-00-DX2.C986EA9D-3AA9-4B81-8CCC-9B533B763163,TCGA-BK-A139,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,5.0,74.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,,943.0,[Not Available],Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],,,0.0,943.0,0.0,943.0,,,0.0,684.0,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,943.0,,,0.0,684.0,0.0,684.0,0.0,684.0
TCGA-BK-A139,TCGA-BK-A139-02Z-00-DX1.14D0CB22-0AF7-480A-A15A-59EA14119AD6,TCGA-BK-A139,Primary,TCGA-UCEC,Endometrium,F,UCEC,Endometrial Carcinoma,BK,True,0.2468,40,40.0,UTERUS,,74.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,,943.0,[Not Available],Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],,,0.0,943.0,0.0,943.0,,,0.0,684.0,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,943.0,,,0.0,684.0,0.0,684.0,0.0,684.0
TCGA-BK-A139,TCGA-BK-A139-01Z-00-DX3.D7636AED-FC27-4996-B709-DF8C865C91D4,TCGA-BK-A139,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2527,40,40.0,UTERUS,,74.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27077.0,Dead,WITH TUMOR,,943.0,[Not Available],Locoregional Recurrence,"Other, specify",Paravaginal mass involving the bladder and rectal walls,684.0,[Discrepancy],,,0.0,943.0,0.0,943.0,,,0.0,684.0,,0.0,684.0,0.0,684.0,0.0,684.0,0.0,943.0,,,0.0,684.0,0.0,684.0,0.0,684.0
TCGA-BK-A13B,TCGA-BK-A13B-01Z-00-DX1.674013BE-4F59-4ED4-B35D-E9F683C75772,TCGA-BK-A13B,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,5.0,58.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493.0,Alive,WITH TUMOR,966.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal,760.0,Complete Remission/Response,,,1.0,966.0,1.0,966.0,0.0,760.0,0.0,760.0,,0.0,760.0,0.0,760.0,0.0,760.0,1.0,966.0,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0
TCGA-BK-A13B,TCGA-BK-A13B-01Z-00-DX2.94ED8CB1-3FF7-42FC-8E1E-D089C6AE4B98,TCGA-BK-A13B,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,,58.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-21493.0,Alive,WITH TUMOR,966.0,,[Not Available],Locoregional Recurrence,"Other, specify",Vaginal,760.0,Complete Remission/Response,,,1.0,966.0,1.0,966.0,0.0,760.0,0.0,760.0,,0.0,760.0,0.0,760.0,0.0,760.0,1.0,966.0,0.0,760.0,0.0,760.0,0.0,760.0,0.0,760.0
TCGA-BK-A13C,TCGA-BK-A13C-01Z-00-DX2.BA3E7B9E-44A3-42A5-9971-9E830653443B,TCGA-BK-A13C,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2465,40,40.0,UTERUS,4.0,47.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-17317.0,Alive,TUMOR FREE,760.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0
TCGA-BK-A13C,TCGA-BK-A13C-01Z-00-DX1.5DB9EB77-5E29-479F-BC6E-0D5A404E10CD,TCGA-BK-A13C,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2456,40,40.0,UTERUS,,47.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2010.0,Peri (6-12 months since last menstrual period),-17317.0,Alive,TUMOR FREE,760.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0,1.0,760.0
TCGA-BK-A26L,TCGA-BK-A26L-01Z-00-DX1.0D83E5C4-42EA-45C9-960D-C08F47E18D7A,TCGA-BK-A26L,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,BK,True,0.248,40,40.0,UTERUS,4.0,71.0,WHITE,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26002.0,Alive,TUMOR FREE,734.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0,,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0,1.0,734.0
TCGA-BK-A4ZD,TCGA-BK-A4ZD-01Z-00-DX1.1B337A42-A701-4540-A037-6198AC42BBB6,TCGA-BK-A4ZD,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.248,40,40.0,UTERUS,2.0,42.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G3,2012.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-15536.0,Alive,TUMOR FREE,506.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0,,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0,1.0,506.0
TCGA-BK-A56F,TCGA-BK-A56F-01Z-00-DX1.1EED86C7-1873-4008-8EC7-42F6D93C955A,TCGA-BK-A56F,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2456,40,40.0,UTERUS,2.0,75.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27523.0,Alive,TUMOR FREE,401.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0,,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0,1.0,401.0
TCGA-BK-A6W3,TCGA-BK-A6W3-01Z-00-DX1.91EB5717-F6E5-46F0-B8CB-F06FE67B1B2F,TCGA-BK-A6W3,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2456,40,40.0,UTERUS,1.0,34.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G2,2013.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-12590.0,Alive,TUMOR FREE,305.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0,,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0,1.0,305.0
TCGA-BK-A6W4,TCGA-BK-A6W4-01Z-00-DX1.1C36AB2B-FC3E-4F51-A18A-1B3080E18672,TCGA-BK-A6W4,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,BK,True,0.2456,40,40.0,UTERUS,1.0,62.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22766.0,Alive,TUMOR FREE,300.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0,,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0,1.0,300.0
TCGA-EC-A1NJ,TCGA-EC-A1NJ-01Z-00-DX1.B7CD1F9E-98A5-4CFD-8138-4920505E1670,TCGA-EC-A1NJ,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,EC,True,0.2485,40,40.0,UTERUS,2.0,73.0,WHITE,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27002.0,Alive,TUMOR FREE,488.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0,,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0,1.0,488.0
TCGA-EC-A1QX,TCGA-EC-A1QX-01Z-00-DX1.D94B9C3B-F06F-4300-B492-E2534AF4D703,TCGA-EC-A1QX,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,EC,True,0.2456,40,40.0,UTERUS,0.0,71.0,WHITE,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G3,2010.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26259.0,Alive,TUMOR FREE,224.0,,[Not Available],,,,219.0,Progressive Disease,,,1.0,224.0,1.0,224.0,,,0.0,219.0,,0.0,219.0,,,0.0,219.0,1.0,224.0,,,0.0,219.0,0.0,219.0,,
TCGA-EC-A24G,TCGA-EC-A24G-01Z-00-DX1.B15DA038-C4C8-4231-9821-BB6EE6A0D758,TCGA-EC-A24G,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,EC,True,0.2468,40,40.0,UTERUS,2.0,57.0,WHITE,[Not Applicable],Stage II,Endometrioid endometrial adenocarcinoma,G3,2011.0,Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement),-20857.0,Alive,TUMOR FREE,511.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0,,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0,1.0,511.0
TCGA-JU-AAVI,TCGA-JU-AAVI-01Z-00-DX1.35992BA3-2E87-4584-B2A9-B1DE21C66E04,TCGA-JU-AAVI,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,JU,True,0.2525,40,40.0,UTERUS,3.0,61.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289.0,Dead,WITH TUMOR,,540.0,[Not Available],Distant Metastasis,"Other, specify",Porta Hepatis,505.0,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,505.0,0.0,505.0,,0.0,505.0,0.0,505.0,0.0,505.0,0.0,540.0,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0
TCGA-JU-AAVI,TCGA-JU-AAVI-01Z-00-DX2.ECF6F478-03AD-4876-81BD-6B2AF7639C50,TCGA-JU-AAVI,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,JU,True,0.2525,40,40.0,UTERUS,,61.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIC1,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22289.0,Dead,WITH TUMOR,,540.0,[Not Available],Distant Metastasis,"Other, specify",Porta Hepatis,505.0,Complete Remission/Response,,,0.0,540.0,0.0,540.0,0.0,505.0,0.0,505.0,,0.0,505.0,0.0,505.0,0.0,505.0,0.0,540.0,0.0,505.0,0.0,505.0,0.0,505.0,0.0,505.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX8.8B5C9140-CDE8-47F6-B847-F5CFB92399CD,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,3.0,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX5.5D10994A-40E6-4327-A9C0-6FEA2AC6B771,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX6.D526A895-B369-47B9-8903-8731BCD0A1BB,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX3.001CCA67-1A3A-45FB-AA92-36011BDF9D02,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX4.860CCC5D-05A1-4630-8AE0-620825609F83,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX2.0681A7E4-EB48-49F2-8CE9-5BE2154FC05D,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX1.B19A6D20-0D68-4C34-8FE2-EB8B42B98100,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A5BC,TCGA-PG-A5BC-01Z-00-DX7.267346BC-B6C5-4613-9B19-460672319141,TCGA-PG-A5BC,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2456,40,40.0,UTERUS,,72.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage II,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26436.0,Alive,TUMOR FREE,707.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0,1.0,707.0
TCGA-PG-A6IB,TCGA-PG-A6IB-01Z-00-DX4.631A44B6-43E0-4481-AF1F-3EB484784672,TCGA-PG-A6IB,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2468,40,40.0,UTERUS,3.0,68.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0
TCGA-PG-A6IB,TCGA-PG-A6IB-01Z-00-DX1.575AC6BD-6ABA-468D-9A46-DC61BD92269C,TCGA-PG-A6IB,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2468,40,40.0,UTERUS,,68.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0
TCGA-PG-A6IB,TCGA-PG-A6IB-01Z-00-DX3.82A8C097-478B-4B6E-BB16-7461529B524F,TCGA-PG-A6IB,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2468,40,40.0,UTERUS,,68.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0
TCGA-PG-A6IB,TCGA-PG-A6IB-01Z-00-DX2.C943409D-2569-4C84-874A-773AC7CEE834,TCGA-PG-A6IB,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2468,40,40.0,UTERUS,,68.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-24969.0,Alive,TUMOR FREE,648.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0,1.0,648.0
TCGA-PG-A7D5,TCGA-PG-A7D5-01Z-00-DX1.3B12F210-014B-408D-83A9-9D23BD5E306A,TCGA-PG-A7D5,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,6.0,62.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2011.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-23006.0,Alive,TUMOR FREE,1177.0,,[Not Available],,,,,Stable Disease,,,1.0,1177.0,1.0,1177.0,,,1.0,1177.0,,1.0,1177.0,1.0,1177.0,1.0,1177.0,1.0,1177.0,,,1.0,1177.0,1.0,1177.0,1.0,1177.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX1.84F19325-D7E3-4CB3-B887-05C7D7D7A9CF,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,3.0,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX4.33C67F98-A8C3-4C3A-B630-D12014C645EC,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX2.3E26BE80-C385-4DB2-AECC-B5E607BC1FEB,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX6.AF10CFC6-3016-4523-9A01-5EF8A06B3CDD,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX3.AB9CCE16-89DF-4C0F-AB07-E5CA4E168EC6,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A914,TCGA-PG-A914-01Z-00-DX5.75C61081-9AB3-4237-B2CE-EFCBA1F22343,TCGA-PG-A914,Primary,TCGA-UCEC,Endometrium,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,73.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-26992.0,Alive,TUMOR FREE,687.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0,1.0,687.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX6.32D62843-11DB-4653-990E-80A3EEB59612,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,3.0,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX5.C87132C9-F354-4EAD-A89C-DF85D3890338,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX7.1F385796-7AEC-43CE-9F6A-564204BA9BE6,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX3.9D178CFC-D024-4C63-8D5F-6884ED1D835B,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX2.E6AFA173-6E18-4194-BB65-9BD7F7652237,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX1.EE02736A-4198-4880-9791-8AA6899533D1,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A916,TCGA-PG-A916-01Z-00-DX4.970A790E-649C-4D4D-98DB-7DF6A7045A14,TCGA-PG-A916,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,70.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage I,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-25617.0,Alive,TUMOR FREE,522.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0,1.0,522.0
TCGA-PG-A917,TCGA-PG-A917-01Z-00-DX2.DFE283A9-971C-4114-A06D-28FEB52AAA7A,TCGA-PG-A917,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,0.0,74.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0
TCGA-PG-A917,TCGA-PG-A917-01Z-00-DX1.4DB12583-7DA3-4110-A3F9-F31B9ADA0A24,TCGA-PG-A917,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,74.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0
TCGA-PG-A917,TCGA-PG-A917-01Z-00-DX3.9F8BF767-4F44-4B89-B852-FB826C3E0BAE,TCGA-PG-A917,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,PG,True,0.2525,40,40.0,UTERUS,,74.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IA,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-27104.0,Alive,TUMOR FREE,212.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0,1.0,212.0
TCGA-QS-A5YQ,TCGA-QS-A5YQ-01Z-00-DX1.DDF17CB8-4995-4A4D-AFA7-E84BEEA84E3F,TCGA-QS-A5YQ,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,QS,True,0.2456,40,40.0,UTERUS,4.0,55.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Endometrioid endometrial adenocarcinoma,G1,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-20425.0,Alive,TUMOR FREE,759.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0,,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0,1.0,759.0
TCGA-QS-A5YR,TCGA-QS-A5YR-01Z-00-DX1.3B65C669-FFEB-4177-A70A-4CD14FA3559A,TCGA-QS-A5YR,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,QS,True,0.2456,40,40.0,UTERUS,4.0,61.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22372.0,Alive,WITH TUMOR,719.0,,[Not Available],,,,,Stable Disease,,,1.0,719.0,1.0,719.0,,,1.0,719.0,,1.0,719.0,1.0,719.0,1.0,719.0,1.0,719.0,,,1.0,719.0,1.0,719.0,1.0,719.0
TCGA-QS-A744,TCGA-QS-A744-01Z-00-DX1.6C0B931D-D179-4707-A685-B53C0E4A57E3,TCGA-QS-A744,Primary,TCGA-UCEC,Isthmus uteri,F,UEC,Uterine Endometrioid Carcinoma,QS,True,0.2527,40,40.0,UTERUS,2.0,86.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIB,Endometrioid endometrial adenocarcinoma,G2,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31520.0,Alive,TUMOR FREE,451.0,,[Not Available],,,,,[Not Applicable],,,1.0,451.0,1.0,451.0,,,1.0,451.0,,1.0,451.0,1.0,451.0,1.0,451.0,1.0,451.0,,,1.0,451.0,1.0,451.0,1.0,451.0
TCGA-QS-A8F1,TCGA-QS-A8F1-01Z-00-DX1.D740D7C3-45FB-4EB3-A704-D698ED825B8F,TCGA-QS-A8F1,Primary,TCGA-UCEC,Fundus uteri,F,USC,Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma,QS,True,0.2527,40,40.0,UTERUS,0.0,85.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IIIA,Serous endometrial adenocarcinoma,G3,2013.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-31386.0,Dead,WITH TUMOR,,135.0,[Not Available],,,,,Progressive Disease,,,0.0,135.0,0.0,135.0,,,0.0,135.0,,0.0,135.0,0.0,135.0,0.0,135.0,0.0,135.0,,,0.0,135.0,0.0,135.0,0.0,135.0
TCGA-SJ-A6ZI,TCGA-SJ-A6ZI-01Z-00-DX1.87B9D431-5067-4E93-911C-5B1E58995DDB,TCGA-SJ-A6ZI,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,SJ,True,0.2525,40,40.0,UTERUS,3.0,64.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G1,2013.0,[Unknown],-23653.0,Alive,TUMOR FREE,631.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0,,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0,1.0,631.0
TCGA-SJ-A6ZJ,TCGA-SJ-A6ZJ-01Z-00-DX1.461CC2E8-975E-493E-BA6C-38F0C2428272,TCGA-SJ-A6ZJ,Primary,TCGA-UCEC,Endometrium,F,UEC,Uterine Endometrioid Carcinoma,SJ,True,0.2525,40,40.0,UTERUS,3.0,61.0,BLACK OR AFRICAN AMERICAN,[Not Applicable],Stage IB,Endometrioid endometrial adenocarcinoma,G2,2012.0,Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy),-22597.0,Alive,TUMOR FREE,556.0,,[Not Available],,,,,Complete Remission/Response,,,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0,,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0,1.0,556.0
